GlassScriptPhysician profile
Krishna P Jayaraman
NPI 1346246881
$5,366.38
in general payments reported to CMS, 2019-2025
42 companies · $849 in 2025
The $849 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $598 · 2020: $473 · 2021: $1,042 · 2022: $829 · 2023: $764 · 2024: $812 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,416 · Education: $8.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,416.05 |
| Education | $8.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $829.39 | 2019-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $687.17 | 2020-2025 | |
| Endo Pharmaceuticals INC. | $409.49 | 2019-2024 | Aveed, Xiaflex |
| Astellas Pharma US INC | $381.36 | 2019-2025 | Xtandi, Veozah |
| Pfizer INC. | $379.71 | 2019-2025 | |
| Endo USA, INC. | $207.22 | 2024-2025 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $185.08 | 2023-2025 | Gemtesa, Orgovyx |
| Acerus Pharmaceuticals Corporation | $178.24 | 2020-2022 | |
| Antares Pharma, INC. | $176.83 | 2019-2024 | Xyosted, Tlando, Nocdurna |
| Abbvie INC. | $175.00 | 2019-2025 | |
| Allergan, INC. | $156.83 | 2019-2021 | |
| Laborie Medical Technologies Corp. | $155.44 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology |
| Coloplast Corp | $114.98 | 2021-2025 | Speedicath |
| Tolmar, INC. | $106.91 | 2023-2025 | Jatenzo, Eligard |
| Tolmar Pharmaceuticals, INC. | $94.73 | 2019-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Krishna Jayaraman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.